Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05617794

Effect of Diffusion Optics Technology (DOT) Spectacle Lenses on Choroidal Thickness

Effect of Diffusion Optics Technology (DOT) Spectacle Lenses on Choroidal Thickness and Choroidal Vascularity Index in Emmetropes

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
SightGlass Vision, Inc. · Industry
Sex
All
Age
8 Years – 14 Years
Healthy volunteers
Accepted

Summary

The objective of the study is to measure the effect of Diffusion Optics Technology (DOT) spectacle lenses on the choroidal thickness and choroidal vascularity index compared to control lenses.

Conditions

Interventions

TypeNameDescription
DEVICEDiffusion Optics Technology (DOT) Pattern Spectacle LensDOT Pattern Spectacle Lens
DEVICEControl Spectacle LensControl Spectacles

Timeline

Start date
2023-01-18
Primary completion
2023-04-30
Completion
2026-03-31
First posted
2022-11-15
Last updated
2024-12-20

Locations

1 site across 1 country: Canada

Regulatory

Source: ClinicalTrials.gov record NCT05617794. Inclusion in this directory is not an endorsement.